Sudeep Pharma Limited (NSE:SUDEEPPHRM)
India · Delayed Price · Currency is INR 1,207.60
-0.10 (-0.01%)
Nov 12, 2026, 3:29 PM IST
Sudeep Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 136,397 | 66,928 | - | - | - | - | |
Market Cap Growth | - | - | - | - | - | - |
Enterprise Value | 137,295 | 67,823 | - | - | - | - |
Last Close Price | 1205.50 | 591.50 | - | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 72.76 | 38.71 | - | - | - | - |
Forward PE | 64.72 | 35.53 | - | - | - | - |
PS Ratio | 19.22 | 10.42 | - | - | - | - |
PB Ratio | 14.02 | 7.45 | - | - | - | - |
P/TBV Ratio | 15.54 | 8.28 | - | - | - | - |
P/OCF Ratio | 143.09 | 96.23 | - | - | - | - |
PEG Ratio | 4.01 | 3.01 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 19.35 | 10.56 | - | - | - | - |
EV/EBITDA Ratio | 54.78 | 30.71 | - | - | - | - |
EV/EBIT Ratio | 58.78 | 32.75 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.20 | 0.17 | 0.28 | 0.22 | 0.37 | 0.52 |
Debt / EBITDA Ratio | 0.76 | 0.68 | 0.72 | 0.43 | 0.93 | 1.23 |
Debt / FCF Ratio | - | - | - | 5.01 | 66.90 | - |
Net Debt / Equity Ratio | 0.08 | 0.04 | 0.17 | 0.18 | 0.31 | 0.39 |
Net Debt / EBITDA Ratio | 0.30 | 0.16 | 0.45 | 0.36 | 0.79 | 0.92 |
Net Debt / FCF Ratio | -1.91 | -2.26 | -5.52 | 4.12 | 56.16 | -1.05 |
Asset Turnover | 0.61 | 0.68 | 0.82 | 0.98 | 1.12 | - |
Inventory Turnover | 1.11 | 1.34 | 1.72 | 2.44 | 3.47 | - |
Quick Ratio | 1.45 | 1.91 | 1.54 | 1.33 | 0.81 | 0.94 |
Current Ratio | 2.91 | 3.09 | 2.43 | 2.01 | 1.35 | 1.33 |
Return on Equity (ROE) | 22.04% | 25.05% | 32.68% | 45.99% | 32.28% | - |
Return on Assets (ROA) | 12.60% | 13.68% | 18.22% | 23.15% | 13.28% | - |
Return on Invested Capital (ROIC) | 17.81% | 20.93% | 27.24% | 36.93% | 22.70% | 40.41% |
Return on Capital Employed (ROCE) | 21.60% | 21.30% | 33.10% | 45.90% | 32.60% | 32.40% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 1.37% | 2.58% | - | - | - | - |
FCF Yield | -0.29% | -0.24% | - | - | - | - |
Dividend Yield | 0.12% | 0.25% | - | - | - | - |
Buyback Yield / Dilution | -4.52% | -2.80% | - | - | - | -361.48% |
Total Shareholder Return | -4.40% | -2.54% | - | - | - | -361.48% |